Pharmaceutical use and costs in patients with coronary artery disease, using Australian observational data

OBJECTIVES: We aimed to estimate the annual pharmaceutical costs for patients with stable coronary artery disease, using Australian administrative data, comparing patients who had undergone interventional treatment with those had not. We also aimed to compare the duration of dual antiplatelet therap...

Descripción completa

Detalles Bibliográficos
Autores principales: McCreanor, Victoria, Parsonage, William A, Whiteman, David C, Olsen, Catherine, Barnett, Adrian G, Graves, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830622/
https://www.ncbi.nlm.nih.gov/pubmed/31678937
http://dx.doi.org/10.1136/bmjopen-2019-029360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830622/
https://www.ncbi.nlm.nih.gov/pubmed/31678937
http://dx.doi.org/10.1136/bmjopen-2019-029360

Ejemplares similares